NFE2L2 is constitutively active in human acute myeloid leukemia (AML) cells, and these cells possess greater constitutive nuclear levels of NFE2L2 than normal control CD34+ cells [17]. The gene discussed is NFE2L2; the disease is acute myeloid leukemia.